Helixmith Co., Ltd (KOSDAQ:084990)
3,175.00
-195.00 (-5.79%)
Nov 20, 2026, 3:30 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 146.2 billion as of November 20, 2026. It is the 24,016th most valuable company in the world and the 939th biggest in South Korea. Its market cap has decreased by 41.74% in one year.
Market Cap
146.20B
Enterprise Value
99.10B
Revenue
2.30B
Global Rank
Country Rank
#939 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 29, 2005, Helixmith's market cap has decreased from 238.64B to 146.20B, a decrease of -38.74%. That is a compound annual growth rate of -2.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 146.20B | -48.95% |
| Dec 30, 2025 | 286.41B | 130.37% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SillaJen | 258.82B |
| Bioneer | 200.55B |
| Genomictree | 198.81B |
| GC Genome | 182.58B |
| GC Cell | 148.32B |
| NeoImmuneTech | 139.40B |
| Anterogen.Co.,Ltd. | 129.88B |
| MedPacto | 125.28B |